Skip to NavigationSkip to content

Pharmafile - Research and Development News

Taspoglutide shows a positive effect on reducing blood glucose in phase III trial
Strativa's novel nausea product dogged by oversees inspection delays
GSK's Harlow R&D site
But dismisses reports 380 posts will be lost at its UK depression research centre
Collaborates with Qiagen on companion diagnostic kit for gliobastoma multiforme treatment
Launches new specialist R&D unit
The ABPI’s director general talks to Pharmafocus about the promise of the new Blueprint
Andrew Witty
Witty sidesteps questions about the internal fall-out from its new plan to slash R&D infrastructure costs
Apeiron's Hans Loibner
Signs £216m deal for phase I candidate with Austrian biotech Apeiron
Follows disciplinary ruling against researcher Dr Wakefield
The EMA's new website
Its new visual identity in place Europe's regulator is gearing up to launch a new public website
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches